Biosense Webster Presents Late-Breaking Data from inspIRE and admIRE Clinical Trials at AF Symposium ...Middle East

Final results from inspIRE study demonstrate 80% freedom from atrial arrhythmia recurrence at 12 months in patients with optimal Pulsed Field Ablation applications First look results from admIRE study suggests similar outcomes IRVINE, Calif., Feb. 2, 2024 /PRNewswire/ -- Biosense Webster,...

Read More Details
Finally We wish PressBee provided you with enough information of ( Biosense Webster Presents Late-Breaking Data from inspIRE and admIRE Clinical Trials at AF Symposium )

Also on site :

• Fresh sirens in north Israel warning of Iran missiles: army
• Target's 'Top-Selling' $5 Backpack Is Heading Back to Stores This Year
• Eastbourne Open 2025 TV channel and live stream: How to watch live coverage